Literature DB >> 3879339

Ascorbic acid reduces the dopamine depletion induced by MPTP.

G C Wagner, M F Jarvis, R M Carelli.   

Abstract

The administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice was found to cause a long-lasting depletion of striatal dopamine concentrations, but did not alter striatal serotonin concentrations. The concomitant administration of ascorbic acid attenuated this MPTP-induced dopamine depletion. These observations are discussed in reference to the possible mechanisms through which MPTP exerts its neurotoxic actions on dopaminergic neurons.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3879339     DOI: 10.1016/0028-3908(85)90164-9

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  6 in total

1.  Strategies for the protection of dopaminergic neurons against neurotoxicity.

Authors:  M Gerlach; K L Double; M B Youdim; P Riederer
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 2.  Parkin and mitophagy in cancer.

Authors:  J P Bernardini; M Lazarou; G Dewson
Journal:  Oncogene       Date:  2016-09-05       Impact factor: 9.867

3.  Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders. An overview.

Authors:  D Metodiewa; C Kośka
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

4.  Effects of low selenium diets on antioxidant status and MPTP toxicity in mice.

Authors:  M S Sutphin; T D Buckman
Journal:  Neurochem Res       Date:  1991-12       Impact factor: 3.996

5.  Pretreatment of Ascorbic Acid Inhibits MPTP-Induced Astrocytic Oxidative Stress through Suppressing NF-κB Signaling.

Authors:  Xiaokang Zeng; Kai Xu; Ji Wang; Yunqi Xu; Shaogang Qu
Journal:  Neural Plast       Date:  2020-11-17       Impact factor: 3.599

6.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.